TP53 and fatty liver disease: In rat models of fatty liver disease, animals with more enhanced subcutaneous fat tissue and liver fat gain, categorized as obesity-prone, showed higher mRNA levels of p16 and p21 but lower expression of p53 and phosphorylated retinoblastoma 1 (Rb1) [50].